Products for Research Use Only
RegisterLogin

Rademikibart

CAT: 0804-HY-P990090-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990090-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rademikibart (CBP-201) is a human monoclonal antibody targeting IL-4Rα with a KD of 20.7 pM when binding to human IL-4Rα epitopes. Rademikibart does not bind to IL-4Rα from other species. Rademikibart inhibits IL-4 and IL-13-mediated STAT6 signaling, TF-1 cell proliferation and TARC production in PBMCs. Rademikibart has the potential for moderate-to-severe Th2 inflammatory diseases research[1].
CAS Number
2648260-80-2
Product Name Alternative
CBP-201
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rademikibart.html
Purity
98.69
Solubility
10 mM in DMSO
Smiles
[Rademikibart]
Molecular Weight
(145.36 kDa)
References & Citations
[1]Limin Zhang, et al. Preclinical immunological characterization of rademikibart (CBP-201), a next-generation human monoclonal antibody targeting IL-4Rα, for the treatment of Th2 inflammatory diseases. Sci Rep. 2023 Jul 31;13 (1) :12411.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T81314-01Rademikibart
GTR18333824-01Rademikibart Antibody
HB732136-01Research Grade Rademikibart
E55B1056Rademikibart (Reference antibody)
ICH5271-5mgRademikibart Biosimilar - Research Grade
GTR18780313-01(Rademikibart) Biosimilar Reference Antibody
A138524Rademikibart Biosimilar (Monoclonal, IgG4)
GTR18695970-01Rademikibart Human Monoclonal Antibody
RA0392-01Rademikibart (Biosimilar Reference Antibody) (IL4R)
MBS1881597-01Anti-IL4RA (rademikibart biosimilar) mAb

Popular Products